Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

3.5K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.5K
Drug Biotransformation: Overview01:28

Drug Biotransformation: Overview

2.4K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
2.4K
Drug Delivery: Overview01:16

Drug Delivery: Overview

703
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
703
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

3.7K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physical activity levels may impact on the risk of premature mortality in people with epilepsy.

Nature communications·2025
Same author

Uncertainty-aware ensemble of foundation models differentiates glioblastoma from its mimics.

Nature communications·2025
Same author

Pancancer outcome prediction via a unified weakly supervised deep learning model.

Signal transduction and targeted therapy·2025
Same author

Deep Learning-Enabled Integration of Histology and Transcriptomics for Tissue Spatial Profile Analysis.

Research (Washington, D.C.)·2025
Same author

A pathology foundation model for cancer diagnosis and prognosis prediction.

Nature·2024
Same author

Predicting physical functioning status in older adults: insights from wrist accelerometer sensors and derived digital biomarkers of physical activity.

Journal of the American Medical Informatics Association : JAMIA·2024
Same journal

STED: flexible cross-modal topic modeling infers cell-type-specific regulatory landscapes from bulk epigenomics.

Briefings in bioinformatics·2026
Same journal

A knowledge-guided deep learning framework for quantitative nucleic acid testing.

Briefings in bioinformatics·2026
Same journal

Optimal transport for label transfer in single-cell multi-omics integration.

Briefings in bioinformatics·2026
Same journal

Continuous multi-omics pathway enrichment analysis resolves hidden functional heterogeneity.

Briefings in bioinformatics·2026
Same journal

Evaluating completeness, coherence, and consistency of genome-scale function annotations.

Briefings in bioinformatics·2026
Same journal

Transformers for single-cell RNA sequencing: a survey.

Briefings in bioinformatics·2026
See all related articles

Related Experiment Video

Updated: Jan 9, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

Prompt-based multimodal representation learning for drug repurposing.

Jinliang Liu1,2, Kaicheng U3, Dhruv Rana4

  • 1School of Computer Science and Artificial Intelligence, Zhengzhou University, No. 100 Science Avenue, Zhengzhou, Henan 450001, China.

Briefings in Bioinformatics
|December 2, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a novel deep learning framework for drug repurposing, improving predictions of compound-protein interactions. The method enhances drug discovery by identifying potential treatments, like non-addictive pain relievers.

Keywords:
drug repurposingmultimodalityprompt learningrepresentation learning

More Related Videos

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.4K
A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning
09:22

A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning

Published on: June 22, 2015

15.0K

Related Experiment Videos

Last Updated: Jan 9, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.4K
A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning
09:22

A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning

Published on: June 22, 2015

15.0K

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Artificial intelligence in medicine

Background:

  • Drug repurposing accelerates drug discovery by reducing costs and timelines.
  • Current deep learning methods often use static molecular structures, limiting the capture of dynamic interactions.
  • Accurate prediction of compound-protein interactions is crucial for effective drug repurposing.

Purpose of the Study:

  • To develop an innovative prompt-based multimodal representation learning framework for enhanced drug repurposing.
  • To address the limitations of static representations in predicting dynamic compound-protein interactions.
  • To improve the accuracy of identifying drug candidates for specific therapeutic targets.

Main Methods:

  • Introduced a prompt-based multimodal representation learning framework.
  • Developed a dynamic prompt generation module for adaptive, receptor-specific prompts.
  • Implemented a prompt calibration module for multimodal feature integration and optimization.
  • Applied the framework to identify FDA-approved drug candidates targeting G-protein-coupled receptors.

Main Results:

  • Achieved a 7.4% improvement in mean absolute error compared to state-of-the-art methods.
  • Demonstrated up to a 25.1% improvement for specific drug targets.
  • Successfully identified potential non-opioid pain management treatments.

Conclusions:

  • The proposed framework enhances the accuracy of compound-protein interaction predictions for drug repurposing.
  • This approach can significantly advance drug discovery, offering solutions for various therapeutic needs, including safe pain management.
  • The dynamic encoding of contextual information is key to improving prediction accuracy.